Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

646 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial.
Stadtmauer EA, Pasquini MC, Blackwell B, Hari P, Bashey A, Devine S, Efebera Y, Ganguly S, Gasparetto C, Geller N, Horowitz MM, Koreth J, Knust K, Landau H, Brunstein C, McCarthy P, Nelson C, Qazilbash MH, Shah N, Vesole DH, Vij R, Vogl DT, Giralt S, Somlo G, Krishnan A. Stadtmauer EA, et al. Among authors: devine s. J Clin Oncol. 2019 Mar 1;37(7):589-597. doi: 10.1200/JCO.18.00685. Epub 2019 Jan 17. J Clin Oncol. 2019. PMID: 30653422 Free PMC article. Clinical Trial.
Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive care.
Holland HK, Dix SP, Geller RB, Devine SM, Heffner LT, Connaghan DG, Hillyer CD, Hughes LL, Miller RL, Moore MR, Winton EF, Wingard JR. Holland HK, et al. Among authors: devine sm. J Clin Oncol. 1996 Apr;14(4):1156-64. doi: 10.1200/JCO.1996.14.4.1156. J Clin Oncol. 1996. PMID: 8648370
Primary amyloidosis patients with significant organ dysfunction tolerate autologous transplantation after conditioning with single-dose total body irradiation alone: a feasibility study.
Blum W, Khoury H, Lin HS, Vij R, Goodnough LT, Devine S, Dipersio J, Adkins D. Blum W, et al. Among authors: devine s. Biol Blood Marrow Transplant. 2003 Jun;9(6):397-404. doi: 10.1016/s1083-8791(03)00106-x. Biol Blood Marrow Transplant. 2003. PMID: 12813448 Free article.
Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
Hallemeier C, Girgis M, Blum W, Brown R, Khoury H, Goodnough LT, Vij R, Devine S, Wehde M, Postma S, Lin HS, Dipersio J, Adkins D. Hallemeier C, et al. Among authors: devine s. Biol Blood Marrow Transplant. 2004 May;10(5):310-9. doi: 10.1016/j.bbmt.2003.12.002. Biol Blood Marrow Transplant. 2004. PMID: 15111930 Free article. Clinical Trial.
Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide.
Girgis M, Hallemeier C, Blum W, Brown R, Lin HS, Khoury H, Goodnough LT, Vij R, Devine S, Wehde M, Postma S, Oza A, Dipersio J, Adkins D. Girgis M, et al. Among authors: devine s. Blood. 2005 Apr 15;105(8):3035-41. doi: 10.1182/blood-2003-07-2346. Epub 2004 May 4. Blood. 2005. PMID: 15126314 Free article.
Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma.
Van Besien K, Mehra R, Wadehra N, Stock W, Khouri I, Giralt S, Devine S, Wickrema A, Peace D, Sosman J, Gajewski J, Champlin R. Van Besien K, et al. Among authors: devine s. Biol Blood Marrow Transplant. 2004 Jun;10(6):386-94. doi: 10.1016/j.bbmt.2004.01.004. Biol Blood Marrow Transplant. 2004. PMID: 15148492 Free article. Clinical Trial.
646 results